Novartis Gets Punitive Damages Barred In Bone Drug Suit

Law360, New York (May 12, 2014, 4:06 PM EDT) -- A North Carolina federal judge overseeing a trial over jaw injuries allegedly caused by Novartis Pharmaceutical Corp.’s bone drugs Zometa and Aredia on Friday said the company can’t be held liable for punitive damages because there isn’t enough evidence to prove its executives acted wrongfully.

Plaintiffs Jimmy and Patricia Earp have alleged that Novartis is liable for punitive damages under North Carolina law because Zometa caused him to develop osteonecrosis of the jaw. The suit is one of a multitude over the drug. But U.S. District Judge James Dever III said in a transcript provided to Law360 that the Earps failed to...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!